Skandinaviska Enskilda Banken (SEB)
SUPN icon

Skandinaviska Enskilda Banken (SEB)’s Supernus Pharmaceuticals SUPN Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-23,200
Closed -$671K – 934
2023
Q4 		$671K Hold
23,200
– – ﹤0.01% 744
2023
Q3 		$639K Sell
23,200
-4,700
-17% -$143K ﹤0.01% 736
2023
Q2 		$840K Buy
+27,900
New +$976K 0.01% 725
2020
Q4 		– Sell
-7,000
Closed -$146K – 1158
2020
Q3 		$146K Buy
+7,000
New +$159K ﹤0.01% 921
2020
Q1 		– Sell
-75,100
Closed -$1.78M – 938
2019
Q4 		$1.78M Buy
75,100
+4,200
+6% +$102K 0.01% 587
2019
Q3 		$1.95M Sell
70,900
-100
-0.1% -$2.96K 0.02% 552
2019
Q2 		$2.35M Sell
71,000
-9,700
-12% -$332K 0.02% 465
2019
Q1 		$2.83M Buy
80,700
+5,600
+7% +$208K 0.03% 391
2018
Q4 		$2.5M Sell
75,100
-2,200
-3% -$94.6K 0.02% 412
2018
Q3 		$3.89M Buy
77,300
+26,200
+51% +$1.29M 0.03% 342
2018
Q2 		$3.06M Sell
51,100
-13,400
-21% -$694K 0.03% 347
2018
Q1 		$2.95M Sell
64,500
-14,600
-18% -$609K 0.03% 304
2017
Q4 		$3.15M Buy
+79,100
New +$3.13M 0.03% 351
2016
Q4 		– Sell
-96,200
Closed -$2.38M – 732
2016
Q3 		$2.38M Sell
96,200
-142,500
-60% -$3.23M 0.03% 426
2016
Q2 		$4.86M Sell
238,700
-65,400
-22% -$1.16M 0.05% 254
2016
Q1 		$4.64M Sell
304,100
-104,600
-26% -$1.36M 0.05% 256
2015
Q4 		$5.49M Buy
+408,700
New +$6.32M 0.07% 202

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s SUPN Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Supernus Pharmaceuticals (SUPN) in Q1 2024, closing a stake of 23,200 shares — an estimated $671K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in SUPN in Q4 2015 and held it in 17 quarters. The position peaked at $5.49M in Q4 2015. 251 funds tracked by Wall St. Rank hold SUPN as of Q1 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Supernus Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 23,200 Supernus Pharmaceuticals shares in Q1 2024, an estimated $671K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Supernus Pharmaceuticals in Q4 2015 and held it in 17 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Supernus Pharmaceuticals position peaked at $5.49M in Q4 2015.
  • 251 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.